For the quarter ending 2025-09-30, ACET has $140,479K in assets. $31,337K in debts. $29,099K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 29,099 | 34,720 | ||
| Short-term investments in treasury securities | 73,999 | 90,243 | ||
| Prepaid expenses and other current assets | 3,396 | 2,777 | ||
| Total current assets | 106,494 | 127,740 | ||
| Restricted cash | 2,903 | 2,903 | ||
| Total property and equipment | 43,909 | - | ||
| Less accumulated depreciation and amortization | 25,915 | - | ||
| Property and equipment, net | 17,994 | 19,549 | ||
| Operating lease right-of-use asset | 11,901 | 12,555 | ||
| Finance lease right-of-use asset | 1,077 | - | ||
| Other non-current assets | 110 | 225 | ||
| Total assets | 140,479 | 162,972 | ||
| Accounts payable | 4,287 | 3,292 | ||
| Accrued and other current liabilities | 11,389 | 10,834 | ||
| Operating lease liability | 2,925 | 2,953 | ||
| Finance lease liability | 340 | - | ||
| Total current liabilities | 18,941 | 17,079 | ||
| Operating lease liability, net of current portion | 11,645 | 12,405 | ||
| Finance lease liability, net of current portion | 626 | - | ||
| Other non-current liabilities | 125 | 116 | ||
| Total liabilities | 31,337 | 29,600 | ||
| Common stock, 0.0001 par value, 300,000,000 shares authorized as of september 30, 2025 and december 31, 2024, respectively 83,253,779 and 82,569,168 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 8 | 8 | ||
| Additional paid-in capital | 693,259 | 690,730 | ||
| Accumulated deficit | -584,181 | -557,325 | ||
| Accumulated other comprehensive income | 56 | -41 | ||
| Total stockholders equity | 109,142 | 133,372 | ||
| Total liabilities and stockholders equity | 140,479 | 162,972 | ||
Adicet Bio, Inc. (ACET)
Adicet Bio, Inc. (ACET)